Octave Bioscience, a Menlo Park, CA-based precision care management platform for neurological conditions, raised $35.6 million in a Series C fundraising round led by Byers Capital, Blue Venture Fund, and Northpond Ventures.
More on VC News Daily →
Octave Bioscience, a Menlo Park, CA-based precision care management platform for neurological conditions, raised $35.6 million in a Series C fundraising round led by Byers Capital, Blue Venture Fund, and Northpond Ventures.
More on VC News Daily →
Mevo, a São Paulo-based consumer internet platform, raised $18 million in...
Centivax, Inc., a San Francisco-based universal vaccines developer, raised...
Audicin, a Finland-based real-time nervous system tech company, raised...
Cara, a New York-based AI platform for insurance, raised $8 million in a...
WHOOP, a Boston-based fitness-tracking wristband maker, raised $575...
Wearable Robotics, a Pisa, Italy-based developer of wearable exoskeletons,...
Stay informed on industry shifts, deal trends, and career opportunities in venture capital.